Endogenous infection marker guides antibiotic therapy

(University of Basel) The endogenous infection marker procalcitonin can help to guide the use of antibiotics when treating infections. The course of antibiotic therapy is shortened, and its side effects and mortality rate also decrease, as researchers from the University of Basel and other colleagues report in the journal The Lancet Infectious Diseases. They conducted a meta-analysis of over 6,700 international data sets from patients with respiratory infections.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news